chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Felt sick about 12 hours after the vaccine and still feeling sick a day and a half after. Have had chills, sore injection arm, sore throat and diarrhea. Now my arm is tingling and I have a red square swollen spot at injection site that has just come up. It is very painful and sore.
This case was reported by a nurse and described a 33 year old female subject who experienced the occurrence of hypaesthesia following vaccination with Engerix B for prophylaxis. Medical history and concurrent medications were unknown. On 10 May 2006, the subject received the 1st dose of Engerix B. Within twenty four hours, the subject experienced right sided dyesthesia, fever joint pain and fatigue. The subject was seen in the emergency room. Following consultation with a neurologist, results of a MRI of the brain was normal and the MRI of the cervical spine revealed a bulging disc between C5 and C6. An anti double stain DNA antibody test, laboratory test and urinalysis was normal. The symptoms improved. The Engerix B series was discontinued. The causality was unk. Follow up received on 19 December 2006 indicated the onset of events was 12 May 2006, two days following vaccination with Engerix B. Diagnostic results revealed a negative hepatitis B surface antibody. Hepatitis B series was not completed. The subject continues to have occasional dull aches. The physician considered the events to be a reaction to the hepatitis B vaccination as the diagnostic workup was negative. The subject had hepatitis B immunization in the past without problems.
This spontaneous report as received from a other health professional refers to a male patient in his 70's. The patients' medical history and concurrent conditions were not reported. On an unspecified date in 2011, the patient was vaccinated with the first dose of ZOSTAVAX from and unspecified healthcare provider, (lot number, expiration date, concentration, via, dose and frequency were not reported). Information regarding concomitant medication was not provided. In August 2016, the primary reporter stated that the patient experienced an 'achy" feeling on the right side of his body. He also had some redness on the right side of his chest and the right side of his back. He went to the emergency room and was diagnosed with shingles. At the time of the report, the outcome of shingles was reported as not recovered. The causality between ZOSTAVAX and shingles was not reported. Additional information has been requested.
I had sore throat, muscle and spinal aches. I had a bone aches and fever. I also had respiratory distress with SOB. I having severe fatigue as well. These symptoms have lasted so far 11 days. On March 7th, I tested positive for COVID-19.
Arm is a bit sore; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a female patient who received Herpes zoster (Shingrix) for prophylaxis.  Previously administered products included Shingrix with an associated reaction of illness (1st dose was received in NOV-2019, refer case US2020AMR032124).  On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced pain in arm (Verbatim: Arm is a bit sore). The outcome of the pain in arm was not reported.  The reporter considered the pain in arm to be possibly related to Shingrix.  The company considered the pain in arm to be possibly related to Shingrix.  Linked case(s) involving the same patient: US2020AMR032124  Additional Information: GSK Receipt Date: 05-JUN-2023 This case was reported by the patient via interactive digital media.  The patient was almost forgot to go back for the second shot.  The patient just got her second Shingles shot. Arm was a bit sore and stated that if the first one was an indicator, it would be for about 3 days. Follow-up would not possible as no contact details were available.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR032124:First dose case
Information has been received from a physician concerning a 9 year old female patient who on an unspecified date, the patient had a severe case of varicella. The patient sought unspecified medical attention. On an unspecified date, the patient recovered. Additional information has been requested.
Sore arm; Little bit of itching; Received a third dose; This non-serious case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 62-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included shingrix (1st dose received in early 2022) and shingrix (2nd dose received in early 2022).   In APR-2023, the patient received the 3rd dose of Shingrix (intramuscular). In APR-2023, an unknown time after receiving Shingrix, the patient experienced pain in arm (Verbatim: Sore arm), pruritus (Verbatim: Little bit of itching) and extra dose administered (Verbatim: Received a third dose). The outcome of the pain in arm, pruritus and extra dose administered were unknown.   It was unknown if the reporter considered the pain in arm and pruritus to be related to Shingrix.     It was unknown if the company considered the pain in arm and pruritus to be related to Shingrix.   Additional Information: GSK Receipt Date: 21-APR-2023 Reporter stated that he received a third dose of Shingrix approximately two weeks ago. His first two doses were done in early 2022, February or March, he was not sure.  He has had a sore arm and a "little bit of itching."  The reporter consented to follow up. At the time of reporting, the patient had received the 3th dose of Shingrix , which had led to extra dose administered.
This spontaneous report was received from a physician via company representatives, and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On 24-APR-2014, the patient was vaccinated with an unspecified improperly stored dose of  PNEUMOVAX 23 "10 Single dose 0.5mLVIs 10 SDV" with lot number J009689 and expiration date of 29-JAN-2015 (route of administration and anatomical location were not reported). On unspecified dates, the PNEUMOVAX 23 had four temperature excursions of 32 Fahrenheit (F) Degrees (0 Celsius) for 152 hours, 31 Fahrenheit (F) Degrees (-0.555555556 Celsius) for 32 hours, 33 Fahrenheit (F) Degrees (0.555555556 Celsius) for 88 hours, and 34 Fahrenheit (F) Degrees (1.111111111 Celsius) for 40 hours (lowest recorded temperatures). The vaccine status was reported as "in excursion". The vaccine storage criteria and the vaccine excursion were reported as "Refrigerator(R)". No adverse effects were reported nor was product quality complaint was involved. This is one of several cases received from the same reporter. Additional information has been requested.
Redness, swelling to injection site.  Rb approximately 3in diameter on 04/04/2003-worse 04/06 per mother.
Swelling and redness in both eyes for which I used BENADRYL. Out of date menstrual bleeding. An advance of 10 days to the date on which she was to menstruate.  Dizziness Migraine with nausea Joint pain and extreme tiredness
Pain, swelling, redness, and itching at injection site.  Recommended antihistamine, cold compresses, and analgesic.
p/vax pt woke up @ 1AM w/ c/o weakness, ringing in ears, dizziness, c/o heaviness in chest;c/o nausea;no SOB; then pt fainted;still f/o weakness;
Narrative: Patient admitted 6/19 to Medical Center with complaints of shortness of breath, chest pain and leg pain. Patient was found to have saddleback pulmonary embolism. 92% oxygen saturation on room air. Patient was immediately brought back for an embolectomy. He was found to have a massive PE bilaterally with the right side almost completely blocked. Procedure was successful. Patient reports to this PharmD that he had previously been seen for leg pain prior to the PE and was diagnosed with RLS. No documents to in our system for that encounter.
Patient's symptoms started around 11/17 with numbness and tingling in the hands. This progressed to back pain and numbness and tingling in the feet two days later. She was admitted to Hospital on 11/20 and underwent multiple tests. She received a diagnosis of Guillain-Barre Syndrome on 11/28/2016. She had no recent illness but a flu shot 2 months ago. The vaccine she received was the FLUZONE High Dose 2016-17 SYR.
Very cold; hand hurt so bad; cant shower, sleep or dress bc cant move hands; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (Very cold), PAIN IN EXTREMITY (hand hurt so bad) and LIMB DISCOMFORT (cant shower, sleep or dress bc cant move hands) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced FEELING COLD (Very cold), PAIN IN EXTREMITY (hand hurt so bad) and LIMB DISCOMFORT (cant shower, sleep or dress bc cant move hands). The patient was treated with DIPHENHYDRAMINE CITRATE, IBUPROFEN (MOTRIN PM) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, FEELING COLD (Very cold), PAIN IN EXTREMITY (hand hurt so bad) and LIMB DISCOMFORT (cant shower, sleep or dress bc cant move hands) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.
hest pain, shortness of breath, chills, fatigue, slight cough 12/22/21.   Chest pain, mild shortness of breath, and random sharp pains at random parts of body (wrists, ankles, rib area, neck, temple, chest, back, eyes, thigh, knee, fingers, elbows) continuing 12/23/21-4/30/22. Had 4 pediatrician calls (12/23/21, 1/7/22, 3/22/22, 4/4/22),  2 cardiology appointments (1/24/22 and 5/19/22), *determined chest wall inflammation at this time 2 ECHOs (1/24/22 and 5/19/22), 2 ECGs and Echocardiograms (1/24/22 and 5/19/22), chest xray (4/8/22),  pulmonary specialist appointment (5/5/22),  pulmonary function test and spirometry test (5/5/22).   All test results normal.
Pt recv vax on 10/26/98; on same day pt exp pain, redness, swelling from elbow -shoulder, body pain x 5dy;tx=Rocephin, Keflex, Benadryl, Tylenol
Patient received Covid booster the day before presentation.  She woke up with a feeling that she cannot get any air.   She denies shortness of breath, chest pain, cough/congestion.  Patient has temp of 100.2 F in ER.
Patient received expired dose; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired dose) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 059H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired dose). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received expired dose) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product information was not provided. The patient received second booster dose. Treatment information was not provided.
Left thigh red and swollen. Hydrocortisone, diphenhydramine. Rx' d given 8-19-13 patient to return to clinic as needed.
OFF BALANCE; WHOLE BODY PAIN; CHILLS; NAUSEA; HEART RACING; DIZZINESS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805022,  expiry: UNKNOWN) dose was not reported, administered on 11-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 11-MAR-2021, the subject experienced heart racing. On 11-MAR-2021, the subject experienced dizziness. On 11-MAR-2021, the subject experienced chills. On 11-MAR-2021, the subject experienced nausea. On 12-MAR-2021, the subject experienced whole body pain. On an unspecified date, the subject experienced off balance. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills on 12-MAR-2021, had not recovered from nausea, dizziness, whole body pain, and heart racing, and the outcome of off balance was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure since case was assessed as non serious
cellulitis; This is a spontaneous report from a contactable pharmacist (patient). This 53-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose via an unspecified route of administration on 28Mar2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced cellulitis (hospitalization) on an unspecified date in 2021. The patient received the first dose of the Pfizer Covid 19 vaccine on 28Mar2021. The second dose was due on 18Apr2021. He was hospitalized due to cellulitis and missed the second dose. The event outcome was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Limited information can not support a complete medical assessment. A possible contributory role of BNT162B2 vaccine can not be excluded for the reported event of cellulitis due to temporal relationship.  Case will be re-assessed upon the additional information provided. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
a petechiae type rash; it was a little bit itchy; bright red color overall; a small rash on both legs; like 2 bands around the top of her lower legs down by the ankle; This spontaneous case was reported by a consumer and describes the occurrence of PETECHIAE (a petechiae type rash), RASH PRURITIC (it was a little bit itchy), ERYTHEMA (bright red color overall), RASH (a small rash on both legs) and RASH (like 2 bands around the top of her lower legs down by the ankle) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history). Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) and VITAMINS NOS for an unknown indication.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced PETECHIAE (a petechiae type rash), RASH PRURITIC (it was a little bit itchy), ERYTHEMA (bright red color overall), RASH (a small rash on both legs) and RASH (like 2 bands around the top of her lower legs down by the ankle). On 02-Feb-2021, PETECHIAE (a petechiae type rash), RASH PRURITIC (it was a little bit itchy), ERYTHEMA (bright red color overall), RASH (a small rash on both legs) and RASH (like 2 bands around the top of her lower legs down by the ankle) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications reported were blood pressure medication, vitamins, acetylsalicylic acid for drug use for unknown indication.  Treatment details included Moisturizer.     Reporter did not allow further contact
sick; Initial information received on 09-Dec-2020 regarding an unsolicited valid serious case received from a consumer or non-healthcare professional.  This case involves five patients (unknown demographics) got sick (illness), when received vaccine INFLUENZA VACCINE  The patient's medical history, past medical treatment, vaccination, concomitant medication and family history were not provided.   In 1974, the patients received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) (lot number not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patients got sick (illness) (unknown latency) following the administration of INFLUENZA VACCINE.   The patients were hospitalized for this event.  Laboratory details were not reported.  It was not reported if the patient received a corrective treatment.  The event outcome was unknown for illness.  Batch number has been requested for suspect product for this case.; Sender's Comments: This poorly documented case concerns 5 patients (unknown demographics) who suffered from illness after vaccination with INFLUENZA VACCINE (produced by unknown manufacturer). The time to onset was unknown. Moreover, patient's medical condition at the time of vaccination, lab tests ruling out alternate etiologies were not reported. Based upon the reported information, the role of the vaccine cannot be assessed.
PALM OF HANDS ARE RED; CONGESTED; BOTH LEG MUSCLES HURTING; CHILLS; NAUSEOUS; BOTH EARS STARTED RINGING; VOMITING; COULDN'T SLEEP; HEAD FEELS LIKE IT IS IN A FOG; This spontaneous report received from a patient concerned a 56 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 204A21A, and expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 08-APR-2021, the subject experienced both ears started ringing. On 08-APR-2021, the subject experienced vomiting. On 08-APR-2021, the subject experienced couldn't sleep. On 08-APR-2021, the subject experienced head feels like it is in a fog. On 08-APR-2021, the subject experienced both leg muscles hurting. On 08-APR-2021, the subject experienced chills. On 08-APR-2021, the subject experienced nauseous. On 09-APR-2021, the subject experienced palm of hands are red. On 09-APR-2021, the subject experienced congested. Laboratory data (dates unspecified) included: Rhesus antigen (NR: not provided) Negative. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from both ears started ringing, vomiting, couldn't sleep, both leg muscles hurting, chills, and nauseous, and had not recovered from head feels like it is in a fog, palm of hands are red, and congested. This report was non-serious.
Information has been received from a registered nurse referring to a 32 year old male patient. In approximately October 2014, 6 months ago the patient received his first dose of M-M-R II. On 30-APR-2015, the patient was vaccinated with a dose of PROQUAD (Merck) (subcutaneous, lot # reported as K025759, expiration date: 08-JUN-2016, 0.5ml), in place of the second dose of M-M-R II. No adverse affect was reported. Additional information has been requested.
1.  A day following the vaccine two days of  extreme fatigue .   2. A week following the vaccine, Covid arm, red spot at the location of the vaccine developed into extremely itchy hives, at the arm the vaccine was administered, right arm.  The hives expanded down to the elbow of the right arm throughout the upper arm, right upper chest area and right  upper back area.  The hives lasted for about two weeks.
Pt, who was a successful student at a Montessori school, who fluently spoke 3 languages, and who was skipped a class due to his high achievent, suddently stopped speaking all together a few days after receiving the MMR II shot; he stopped following verbal or non verbal directions/instructions and cues; he stopped functioning all together.  Numerous visits to psychologists and specialists doctors revealed that he became autistic as a result of the MMR II shot.
Pt received vaccinations on 07 April - one in each deltoid.  Pt received Hepatitis B and Anthrax, and documentation was done, but given by someone else (name unknown)  Pt reported warmth in left deltoid for several days, with onset of rash and knot in vaccine adminstration location on 13 April.  Rash grew progressively larger and pt reported on evening of 13 April.  Recorded BP and temperature as being elevated, and referred pt to clinic the next day.  PT has been taking Tylenol for elevated temperature, and seen here in clinic today (14 April).  Vital signs are stable and pt is afebrile.  Rash is approximately 9 cm in diameter with area of induration in the center.
Remember to prep some pain killer!! I was ok in the first 4h. Didn't feel anything. Then my body started feel a bit lethargic. I went to sleep around 9pm but my body was so pain that I couldn't really fall asleep. The whole body was pain. I didn't have short breathe but I had to breathe heavily to catch myself. Until 2am my arms, legs, face and head started numbing and I couldn't even grab anything. My hand were like sprained. That's when my hunsband has to go buy pain killers for me. He also bought thermometer. I checked my Temperature it's was ~96F. I took ibuprofen and some milk, bread and egg. The pain and numbing was getting off after ~40min after I took Ibuprofen. Then I was able to sleep on bed.
This case, manufacturer control number 2015-0179629, received via Gilead, is a non-serious case of a patient who experienced: coughing and wheezing due to asthma, fever, chills and nausea.
pt received first dose of Pfizer and second dose of Moderna. The patient could not find their vaccine card and she thought she had Moderna.
A report has been received from a Physician concerning a 6 year old, female patient. The patient's concurrent disease included asthma. On 28-Sep-2012 the patient had been receiving nasal FLUMIST. On 29-Sep-2012 the patient experienced wheezing a couple of days after receiving FLUMIST and was managed at home. Patient's mother is a nurse practitioner and did not bring the child into the office. Treated the child at home with VENTOLIN and FLOVENT. The patient recovered from the event of wheezing on an unspecified date. The report was considered to be non-serious by reporter.
Blistering rash on scalp, forehead nose. Currently treating with Hydrocortizone  cream. Body temperature 99.8. which lowered to 98.8 within 1 hour  then 98.6 the next hour (5/18). ( I'm usually at 97.5)  Chills, muscle aches, a massive migraine ( I never have migraines), limited nausea.
Right thigh, erythema and induration 3 cm X 4 cm no fever
Patient contacted me on 04/15/2020 at approx. 3:00pm.  Patient said"I have cellulitis in my right arm. I have had this before. What should I do?" I advised her to call her family DR. and to have this taken care of ASAP. I called Patient @9:56 am of 04/16/20 to check on her. She said"the redness is getting better. I thought I would just keep an eye on it. I have not called my Dr. yet." I encouraged her to call her family Dr.
I was fine after both shots. My arm ached a small bit but nothing bad, but now my left arm hurts so bad sometime that i cannot lift it and there are sharp pains like being stabbed in my arm. It stays like that for hours then goes back to a dull ache that is there all the time. I now just made a Dr. appt due to the fact that I feel that it is making the left side of my back and chest ache really bad.